Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Multi-center Study of Mitochondrial Brain Protective Agent Idebenone in the Prevention of Post-stroke Epilepsy

NCT05987397 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

NCT NCT05987397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05987397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Multi-center Study of Mitochondrial Brain Protective Agent Idebenone in the Prevention of Post-stroke Epilepsy
Lead sponsor
Xiangya Hospital of Central South University
Phase
Phase 4
Overall status
Unknown status
Start date
July 5, 2023
Completion date
December 31, 2025
Enrollment
2,700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post stroke epilepsy